| 2018 | | A pharmaceutical composition for preventing or treating neurodegenerative diseases comprising inhibitor for expressing or activating of FcgammaRIIB | 박상면 |
| 2018 | | A pharmaceutical composition for preventing or treating neurodegenerative diseases comprising inhibitor for expressing or activating of SHP-1/-2 | 박상면 |
| - | | ASK1 Inhibitor and Uses Thereof | 김완기 |
| - | | ASK1 Inhibitor and Uses Thereof | 김완기 |
| - | | ASK1 Inhibitor and Uses Thereof | 김완기 |
| - | | ASK1 Inhibitor and Uses Thereof | 김완기 |
| - | | ASK1 Inhibitor and Uses Thereof | 김완기 |
| 2022 | | Biomarkers for diagnosing osteoarthritis | 김유선, 양시영 |
| 2022 | | Composition for inhibition of toxicity of nanoparticles and environmentally-derived microparticles | 강엽, 곽종영, 신태환, 이광, 이다연 |
| 2017 | | Composition for preventing or improving postmenopausal osteoporosis comprising Scopolin | 김정현, 박은국, 양시영, 정선용 |
| 2016 | | Composition for preventing or treating diabetes comprising the extraction of Polysiphonia japonica | 박상면, 차선희 |
| 2022 | | Composition for preventing or treating inflammatory disease comprising prussian blue/pluronic nanoparticle complexes | 양시영 |
| 2023 | | COMPOSITION FOR PREVENTING OR TREATING MITOCHONDRIAL DYSFUNCTION-RELATED DISEASES | 김현미, 주일로 |
| 2017 | | Composition for Preventing or Treating Osteoarthritis Comprising 3'-Siallylactose or Derivatives Thereof | 강이중, 양시영 |
| 2017 | | Composition for Preventing or Treating Osteoarthritis Comprising 6'-Sialyllactose or Salts Thereof | 강이중, 양시영 |
| - | | Composition for preventing or treating osteoarthritis comprising K-7174 | 양시영 |
| - | | Composition for preventing or treating osteoarthritis comprising Neratinib | 김유선, 양시영 |
| - | | Composition for preventing or treating osteoarthritis comprising Selumetinib | 김유선, 양시영 |
| - | | Composition for treating or diagnosing osteoarthritis | 양시영 |
| - | | Composition for treating or diagnosing osteoarthritis targeting ACVR2B | 양시영 |
| - | | Composition for treating or diagnosing osteoarthritis targeting SNCG | 양시영 |
| - | | Composition for Treating Synucleinopathies | 박상면, 최유리 |
| - | | Culture method of dendritic cells | 곽종영 |
| 2012 | | Ethanol―Resistant Yeast Strains and Uses Thereof | 김완기 |
| 2019 | | Long-term three dimensional culturing system of primary hepatocyte using nanofiber and culturing method | 곽종영, 송민규 |
| 2016 | | MANUFACTURING METHOD OF NANOFIBER STRUCTURE COMPRIGING FUCOIDAN WITH ENHANCED CELL ADHESION AND NANOFIBER STRUCTURE COMPRIGING FUCOIDAN MADE BY THE SAME | 곽종영, 김정민 |
| 2020 | | Method for manufacturing polyvinyl alcohol nanofiber membrane enhancing cell specific adhesion | 곽종영, 이광 |
| 2016 | | METHOD OF MANUFACTURING A POLYVINYL ALCOHOL NANOFIBER STRUCTURE FOR CELL CULTURE | 곽종영, 김정민 |
| 2016 | | NANOFIBER STRUCTURE FOR CELL CURTURE, METHOD OF MANUFACTURING THE NANOFIBER STRUCTURE, AND CELL ANALYSIS DEVICE INCLUDING THE NANOFIBER STRUCTURE | 곽종영 |
| 2022 | | PEPTIDE FOR TARGETING TO MITOCHONDRIA | 김현미, 주일로 |
| 2016 | | PHARMACEUTICAL COMPOSITION COMPRISING CYSTEINYL LEUKOTRIENE RECEPTOR ANTAGONIST AND GINKGO BILOBA EXTRACT FOR TREATING OR PREVENTING SENSORINEURAL HEARING LOSS | 김연주, 박상면, 박정섭, 정연훈 |
| - | | PHARMACEUTICAL COMPOSITION COMPRISING METHYLENE BLUE FOR TREATING OR PREVENTING SENSORINEURAL HEARING LOSS | 박상면, 박정섭 |
| - | | Pharmaceutical composition for preventing or treating SNCG overexpression disease comprising an AZ-628 as an active ingredient | 양시영 |
| - | | Pharmaceutical composition for preventing or treating SNCG overexpression disease comprising an PD-184352 as an active ingredient | 양시영 |
| - | | Pharmaceutical Composition for Preventing or Treating Synucleinopathy Comprising Expression or Activation Inhibitor of c-src | 박상면, 최유리 |
| - | | Therapeutic Composition for Synucleinopathies | 박상면, 최유리 |
